The 3X-TGT platform

Single-molecule insight into repeat expansions.

3X-TGT enriches genomic targets for long-read sequencing. Measure repeat length, sequence and native methylation on individual DNA molecules.

Repeat expansions and read length

More than 50 inherited diseases are caused by repeat expansions, among them myotonic dystrophy, Huntington’s disease, Friedreich ataxia, Fuchs endothelial corneal dystrophy and C9orf72 ALS. Short-read sequencing reads a few hundred bases at a time, and an expanded repeat can run to thousands of bases, so short reads detect an expansion but cannot size it.

Read and repeat lengths are drawn to scale.

Somatic expansion

The repeat keeps expanding in the body after birth, so each patient carries a range of repeat lengths that shifts with age and differs between tissues. The length inherited at conception and the rate of expansion both affect when symptoms begin. A standard clinical test reports whether an expansion is present, or a size class. 3X-TGT reads each molecule end to end without amplification, so one sample gives the full distribution of repeat lengths: its lower edge estimates the inherited length, and its spread shows how far the repeat has expanded, two measures a size class cannot provide.

Enrichment and sequencing

For each target, design software selects an enrichment that leaves the target on one long fragment and cuts the rest of the genome short. The DNA is cut with standard reagents, and size selection keeps the long fragments and removes more than 90 percent of the genome.

The enriched molecules are barcoded, pooled and read end to end on a long-read sequencer. No step amplifies the DNA, so the reads reflect the molecules in the sample, and no PCR, Cas9 or capture probes are used. The method is patent pending.

Measurements on each molecule

MeasurementDefinition
Repeat lengthRepeat count on every molecule from both alleles
Allele lengthRepeat count on each copy of the gene, including an estimate of the length inherited at conception
Somatic distributionThe spread of repeat lengths across cells, and how it changes over time
InterruptionsVariant repeats within the tract, placed on each molecule; in DM1, interruptions are associated with later onset and milder disease
Flanking variantsSingle-nucleotide variants near the repeat, which assign each molecule to its chromosome where present
MethylationDNA methylation in and around the repeat, read natively on the same molecule

Methylation calling is in production and is reported on every read.

Read depth and multiplexing

A standard whole genome gives a handful of reads at a disease gene, none long enough to span an expansion. 3X-TGT reads hundreds of molecules per sample across the full expanded allele. Each sample carries its own barcode, so 12 to 24 samples share one flow cell.

Repeat lengths in DM1 blood

Repeat length of individual molecules from the expanded allele of one DM1 blood sampleHistogram of molecule counts in 25-repeat bins from 350 to 1,425 CTG repeats.020406080350 to 374 CTG: 4 molecules375 to 399 CTG: 2 molecules400 to 424 CTG: 5 molecules425 to 449 CTG: 11 molecules450 to 474 CTG: 13 molecules475 to 499 CTG: 16 molecules500 to 524 CTG: 18 molecules525 to 549 CTG: 16 molecules550 to 574 CTG: 31 molecules575 to 599 CTG: 39 molecules600 to 624 CTG: 49 molecules625 to 649 CTG: 50 molecules650 to 674 CTG: 69 molecules675 to 699 CTG: 65 molecules700 to 724 CTG: 69 molecules725 to 749 CTG: 50 molecules750 to 774 CTG: 51 molecules775 to 799 CTG: 34 molecules800 to 824 CTG: 26 molecules825 to 849 CTG: 25 molecules850 to 874 CTG: 13 molecules875 to 899 CTG: 19 molecules900 to 924 CTG: 10 molecules925 to 949 CTG: 6 molecules950 to 974 CTG: 2 molecules975 to 999 CTG: 1 molecules1000 to 1024 CTG: 4 molecules1025 to 1049 CTG: 1 molecules1050 to 1074 CTG: 1 molecules1175 to 1199 CTG: 1 molecules1275 to 1299 CTG: 1 molecules1400 to 1424 CTG: 1 molecules4006008001,0001,2001,400CTG repeats per molecule (expanded allele, 25-repeat bins)Molecules
Each bar counts molecules from the expanded allele of one DM1 blood sample, binned by repeat length; every molecule is sized end to end.

Multiplexed Analysis

On-target molecules per sample, saliva at DMPK and blood at TCF4 on one flow cellSeven saliva samples at DMPK and six blood samples at TCF4; 22 to 643 on-target molecules per sample.0200400600S1 (saliva, DMPK): 22 on-target moleculesS1S2 (saliva, DMPK): 127 on-target moleculesS2S3 (saliva, DMPK): 643 on-target moleculesS3S4 (saliva, DMPK): 68 on-target moleculesS4S5 (saliva, DMPK): 102 on-target moleculesS5S6 (saliva, DMPK): 218 on-target moleculesS6S7 (saliva, DMPK): 152 on-target moleculesS7B1 (blood, TCF4): 80 on-target moleculesB1B2 (blood, TCF4): 81 on-target moleculesB2B3 (blood, TCF4): 93 on-target moleculesB3B4 (blood, TCF4): 105 on-target moleculesB4B5 (blood, TCF4): 280 on-target moleculesB5B6 (blood, TCF4): 242 on-target moleculesB6Saliva, DMPK (S1 to S7)Blood, TCF4 (B1 to B6)On-target molecules
Saliva samples at DMPK and blood samples at TCF4 were sequenced together in one run.

Validation and regulatory status

The method has been demonstrated at DMPK (DM1) and TCF4 (Fuchs endothelial corneal dystrophy) in blood and saliva. It is offered for research use now. The DMPK and TCF4 assays are in analytical validation in the 3X Genetics CLIA-registered laboratory (CLIA ID 22D2345868); Massachusetts clinical laboratory license pending. Clinical testing is planned for 2027, in that laboratory or through a partner CLIA laboratory. A next-generation enrichment method for deep reads from small amounts of DNA is under development.

To discuss the technology or a sample set, contact Steven Oldenburg, PhD: [email protected]